“Our strong first quarter performance gave us the confidence to increase our full year 2026 adjusted earnings per share guidance to a range of $7.30 to $7.50, up from the previous range of $7 to $7.20.”

In context

“h strong momentum, and our intentional execution and deliberate actions across CVS Health have led to another quarter of excellent performance. We are driving improved results at Aetna, while removing friction for members and providers. We remain laser-focused on delivering meaningful savings and the lowest net cost to our clients and members at Caremark. We are executing against our operational plans in health care delivery to improve health care access across the country. And through the dedication and hard work of our colleagues in the communities across the country, we continue to build momentum and expand our position as the best-run national pharmacy. Turning to our results this quarter. We delivered adjusted operating income of $5.2 billion and adjusted earnings per share of $2.57. Our strong first quarter performance gave us the confidence to increase our full year 2026 adjusted earnings per share guidance to a range of $7.30 to $7.50, up from the previous range of $7 to $7.20. Our revised outlook continues to reflect the core principles of our guidance philosophy, credible targets, disciplined execution and clear opportunities for outperformance. Across CVS Health, our teams remain focused on what matters most, improving affordability, reducing friction and delivering a more connected and seamless health care experience. However, to realize our ambition of becoming America's most trusted health care company, we need to drive change across the entire health care ecosystem. We've been focused on strengthening our relationships with all stakeholders to address our key priorities and improve health care for Americans. We share CMS' goal of ensuring the long-term sustainability of the Medicare Advantage program, which remains the best example of a public-private par”